Literature DB >> 29314410

Methods to reduce false reporting of substance abstinence in clinical research.

Sandra J Japuntich1,2, Kimberly A Arditte Hall3,4, Celina M Joos5, Ann M Rasmusson3,4, Suzanne L Pineles3,4.   

Abstract

OBJECTIVES: Substance use may influence study results in human subjects research. This study aims to report the concordance between self-report and biochemical assessments of substance use and test the effect of methods to reduce false reports of abstinence in trauma-exposed women participating in a research study.
METHODS: In this pilot study, substance use was assessed during telephone prescreening and via self-report and biochemical verification (i.e., urine toxicology and alcohol breathalyzer tests) at an in-person evaluation. Due to the high number of participants who tested positive for substances despite self-reporting abstinence during prescreening, study procedures were modified to disincentivize false self-reports of substance use two thirds of the way through recruitment. New potential participants were explicitly informed during prescreening and informed consent that a positive drug or alcohol test during screening would result in exclusion from the study and withholding of payment.
RESULTS: Prior to modifying study methods, 20% of participants who had reported abstinence during the telephone prescreen had a positive substance use test at the in-person visit. Modifying study procedures resulted in an 81% decrease in positive substance use assessments.
CONCLUSIONS: Adoption of this methodology may decrease inadvertent confounding of clinical research outcomes by undetected and/or misreported substance use.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  biochemical verification; drug testing; post-traumatic stress disorder; substance abuse; trauma

Mesh:

Year:  2018        PMID: 29314410      PMCID: PMC6877230          DOI: 10.1002/mpr.1603

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  21 in total

Review 1.  What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?

Authors:  Maria Jose Fernández-Serrano; Miguel Pérez-García; Antonio Verdejo-García
Journal:  Neurosci Biobehav Rev       Date:  2010-05-06       Impact factor: 8.989

Review 2.  Neuroactive steroids and PTSD treatment.

Authors:  Ann M Rasmusson; Christine E Marx; Suzanne L Pineles; Andrea Locci; Erica R Scioli-Salter; Yael I Nillni; Jennifer J Liang; Graziano Pinna
Journal:  Neurosci Lett       Date:  2017-02-12       Impact factor: 3.046

3.  Hair analysis versus conventional methods of drug testing in substance abusers seeking organ transplantation.

Authors:  D L Haller; M C Acosta; D Lewis; D R Miles; T Schiano; P A Shapiro; J Gomez; S Sabag-Cohen; H Newville
Journal:  Am J Transplant       Date:  2010-03-26       Impact factor: 8.086

4.  Denial of urinalysis-confirmed opioid use in prescription opioid dependence.

Authors:  E Yvette Hilario; Margaret L Griffin; R Kathryn McHugh; Katherine A McDermott; Hilary S Connery; Garrett M Fitzmaurice; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2014-07-18

5.  Extinction retention and the menstrual cycle: Different associations for women with posttraumatic stress disorder.

Authors:  Suzanne L Pineles; Yael I Nillni; Matthew W King; Samantha C Patton; Margaret R Bauer; Sheeva M Mostoufi; Megan R Gerber; Richard Hauger; Patricia A Resick; Ann M Rasmusson; Scott P Orr
Journal:  J Abnorm Psychol       Date:  2016-02-11

6.  Menstrual cycle effects on psychological symptoms in women with PTSD.

Authors:  Yael I Nillni; Suzanne L Pineles; Samantha C Patton; Matthew H Rouse; Alice T Sawyer; Ann M Rasmusson
Journal:  J Trauma Stress       Date:  2015-01-22

7.  The utility of drug testing in epidemiological research: results from a general population survey.

Authors:  Michael Fendrich; Timothy P Johnson; Joseph S Wislar; Amy Hubbell; Vina Spiehler
Journal:  Addiction       Date:  2004-02       Impact factor: 6.526

Review 8.  The cannabis withdrawal syndrome: current insights.

Authors:  Udo Bonnet; Ulrich W Preuss
Journal:  Subst Abuse Rehabil       Date:  2017-04-27

Review 9.  Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.

Authors:  Neil P Roberts; Pamela A Roberts; Neil Jones; Jonathan I Bisson
Journal:  Cochrane Database Syst Rev       Date:  2016-04-04

Review 10.  Neurobiology of opioid dependence in creating addiction vulnerability.

Authors:  Christopher J Evans; Catherine M Cahill
Journal:  F1000Res       Date:  2016-07-19
View more
  2 in total

1.  Methods to reduce false reporting of substance abstinence in clinical research.

Authors:  Sandra J Japuntich; Kimberly A Arditte Hall; Celina M Joos; Ann M Rasmusson; Suzanne L Pineles
Journal:  Int J Methods Psychiatr Res       Date:  2018-01-04       Impact factor: 4.035

2.  Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests.

Authors:  Sarah M Bagley; Debbie M Cheng; Michael Winter; Daniel P Alford; Colleen LaBelle; Alexander Y Walley; Jeffrey H Samet
Journal:  Drug Alcohol Depend       Date:  2018-09-25       Impact factor: 4.492

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.